AzTrials
AzTrials

Heart FailureIC-CBCNCT04062461

Evaluate the Effectiveness of Self-care Multifaceted Strategy in Heart Failure Patients

A study testing Multifaceted strategy based on sending text messages(SMS) and Usual outpatient care in people with Heart Failure, run by Hospital do Coracao at 1 site in Brazil.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Study Design: A randomized, multicenter, national, phase II clinical trial aimed at evaluating the effectiveness of self-care promotion using a multifaceted strategy based on sending text messages(SMS)to patients with heart failure. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Heart Failure
What is being tested?
Multifaceted strategy based on sending text messages(SMS) and Usual outpatient care
Could I receive a placebo?
No, everyone receives an active treatment
How many people
704 participants
Where
1 siteBrazil
Study dates
8 Jul 2019to 30 Apr 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adults (> 18 years)
  • Heart failure of any etiology
  • Vulnerable period after episode of acute decompensation
  • Cellular telephony acess;
  • Left Ventricular Ejection Fraction (LVEF <40%),

Who cannot join

  • Cardiac transplant wait list;
  • Surgical or percutaneous (coronary or valvular) treatment at last 3 months
  • HF terminal ;
  • Life expectancy <1 year;
  • Another drug or device study at last 30 days
  • Prior randomization in the study

Trial locations and contacts

1 site in 1 country.

Brazil1 site
  • Hospital de Clínicas de Porto Alegre

    Porto Alegre, Rio Grande do Sul

Other trials in Brazil

About this study

Official title: A Multicenter Randomized Clinical Trial Aimed at Evaluating the Effectiveness of Self-care Promotion in Patients With Heart Failure

Study Design: A randomized, multicenter, national, phase II clinical trial aimed at evaluating the effectiveness of self-care promotion using a multifaceted strategy based on sending text messages(SMS)to patients with heart failure.

Methodological quality:

  • Central randomization with allocation concealment;
  • Decision committee for blind outcome assessment;
  • Intention-to-treat analysis
Read the detailed description

Study Design -A randomized, multicenter, national, phase II clinical trial aimed at evaluating the effectiveness of self-care promotion using a multifaceted strategy based on sending text messages(SMS) to patients with heart failure.

Methodological quality

-Central randomization with allocation concealment; Decision committee for blind outcome assessment; Intention-to-treat analysis

Primary Objective -To develop and evaluate the feasibility of a monitoring, education and self-care strategy to optimize the management of patients with heart failure (HF) after hospital discharge.

Secondary Objectives

-To evaluate, in patients with heart failure, the effect of a self-care promotion program using a multifaceted strategy in comparison to the usual care about acceptability to the application of SMS, patient and / or family satisfaction with care, quality of life scales health scales, self-care scales and knowledge on HF, visual analog scale of dyspnea, and clinical outcomes at 30 and 180 days.

Experimental group:

-Self-care promotion using a multifaceted strategy based on the use of a tele-monitoring device, based on short message system (SMS) messages and self-care teaching tools.

Patients will receive daily messages to optimize self-care in heart failure with the following functions:

  • customized reminders about medication schedules
  • weight and symptoms of decompensation monitoring assessing a decision tree with diuretics adjustment if needed and alerts that define the need to contact a health professional for early intervention before deterioration of the clinical state, identifying situations that require clinical intervention.
  • educational content on heart failure for the patient (symptoms of the disease, healthy habits for HF, warning signs for severity)
  • diary for registration of visits to health services and clinical setting.

Control group:

-Usual outpatient care

Follow-up

  • Follow up will be at least 180 days from the inclusion in the study.
  • Sample size estimation 350 patients per group (700 patients)
Conditions
Heart Failure
Being tested
Multifaceted strategy based on sending text messages(SMS), Usual outpatient care
Medical subject headings
Heart Failure

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Multifaceted strategy based on sending text messages(SMS)Other

    multifaceted strategy based on sending text messages(SMS) to patients with heart failure.

    Press educational content on heart failure for the patient (symptoms of the disease, healthy habits for HF, warning signs for severity).

    The text messages are about how the patient should take your drugs (evem diuretics), measure blood pressure and weight in Kg, and about signals and symptoms (shorthbreathness during the night), and about how important is practice physical exercises and don't drink alcohol.

  • Usual outpatient careOther

    Educational content on heart failure for the patient (symptoms of the disease, healthy habits for HF, warning signs for severity)

Study groups in NCT04062461
Study groupRoleWhat they receive
self-care promotionExperimentalmultifaceted strategy based on sending text messages(SMS) to patients with heart failure. Press educational content on heart failure for the patient (symptoms of the disease, healthy habits for HF, warning signs for severity). The text messages are about how the patient should take your drugs (evem diuretics), measure blood pressure and weight in Kg, and about signals and symptoms (shorthbreathness during the night), and about how important is practice physical exercises and don't drink alcohol.
Receives: Other: Multifaceted strategy based on sending text messages(SMS)
Control groupActive comparatorroutinely management in the HF. Press educational content on heart failure for the patient (symptoms of the disease, healthy habits for HF, warning signs for severity)
Receives: Other: Usual outpatient care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The evaluation of the effect of multifaceted intervention compared to usual outpatient care on the primary endpoint will be performed using the Student's t-Student test of the log ratio of NT-proBNP levels at 6 months baseline.

    Variation of NT-proBNP in 180 days;

    Measured: six months

Secondary outcomes (11)
  1. Overall mortality

    Overall mortality for Heart Failure at 180 days

    Measured: Six months

  2. Overall hospitalization

    Overall hospitalization for Heart Failure at 180 days

    Measured: Six months

  3. Cardiovascular mortality

    To evaluate cardiovascular mortality in 180 days

    Measured: Six months

  4. Emergency department visit

    To evaluate emergency department visit in 180 days

    Measured: Six months

  5. Satisfaction of the patient and / or caregiver with health care

    Using (NPS tool):Scale of 0-10 to measure satisfaction of the patient and / or caregiver with health care. Rate it from 0 to 10, where 0 means not at all satisfied and 10 means extremely satisfied.

    Measured: Thirty days

  6. Acceptability / adherence to the system of sending messages

    Using a Scale of 0-10 (question to insert the note) to measure acceptability / adherence to the system of sending messages. Rate it from 0 to 10, where 0 means no help at all and 10 means the posts were extremely beneficial.

    Measured: Six months

  7. Variation of NT-proBNP in 30 days

    The evaluation of the effect of multifaceted intervention compared to usual outpatient care on the primary endpoint will be performed using the Student's t-Student test of the log ratio of NT-proBNP levels at 30 days from baseline.

    Measured: 30 days

  8. Kansas Health-related quality of life in baseline, 30 and 180 days

    Using (Kansas Health-related quality of life Questionnaire): Scale of 0-100 to measure quality of life in patients with heart failure. Rate it from 0 to 100. Overall score means higher is better.

    Measured: From baseline, 30 and 180 days.

  9. Variation scale numeric of VAS (Visual Analogue Scale) of dyspnea.

    Using Variation scale numeric of VAS (Visual Analogue Scale) to measure degree of dyspnea. Rate from 0 to 10, where 0 means no dyspnea and 10 the highest complain of dyspnea.

    Measured: Baseline, 30, 90 and 180 days visits

  10. European Heart Failure Self-Care Behavior Scale - EHFScBs

    Using (EHFScBs): Scale of 0-60 to to measure self-care behavior of heart failure (HF) patients. Rate it from 0 to 60. Overall score means smaller is better.

    Measured: From 30 and 180 days.

  11. Heart Failure Knowledge Questionnaire

    Used to measure Knowledge about Heart Failure. Are by 14 questions more than 70% of correct answers means good Knowledge.

    Measured: From 30 and 180 days.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Aug 2019
  2. Study start8 Jul 2019
  3. Primary completion6 Jan 2023
  4. Study completion30 Apr 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
A randomized, multicenter, national, phase II clinical trial aimed at evaluating the effectiveness of self-care promotion using a multifaceted strategy based on sending text messages SMS to patients with heart failure.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
704 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04062461
Sponsor's protocol ID
01
Acronym
IC-CBC
Status last verified
Mar 2023
First submitted
13 Jun 2019
Last updated
2 Mar 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Rohde LE, Rover MM, Hoffmann Filho CR, Rabelo-Silva ER, Silvestre OM, Martins SM, Passos LCS, de Figueiredo Neto JA, Danzmann LC, Silveira FS, Mesas CE, Hernandes ME, Moura LZ, Simoes MV, Ritt LEF, Nishijuka FA, Bertoldi EG, Dall Orto FTC, Magedanz EH, Mourilhe-Rocha R, Fernandes-Silva MM, Ferraz AS, Schwartzmann P, de Castilho FM, Pereira Barretto AC, Dos Santos Junior EG, Nogueira PR, Canesin M, Beck-da-Silva L, de Carvalho Silva M, Adolfi Junior MS, Santos RHN, Ferreira A, Pereira D, Lopez Pedraza L, Kojima FCS, Campos V, de Barros E Silva PGM, Blacher M, Cavalcanti AB, Ramires F; MESSAGE-HF Investigators. Multifaceted Strategy Based on Automated Text Messaging After a Recent Heart Failure Admission: The MESSAGE-HF Randomized Clinical Trial. JAMA Cardiol. 2024 Feb 1;9(2):105-113. doi: 10.1001/jamacardio.2023.4501.

    PubMed 38055237
  • Rohde LE, Hoffmann Filho CR, Rover MM, Rabelo-Silva ER, Lopez L, Passos LCS, Silvestre OM, Martins SM, de Figueiredo Neto JA, Silveira FS, Canesin MF, Simoes MV, Akio Nishijuka F, Bertoldi EG, Danzmann LC, Mourilhe-Rocha R, Magedanz EH, Esteves M, de Castilho FM, Fernandes-Silva MM, Ritt LEF, Blacher M, Soares RM, Cavalcanti AB, Ramirez F. Design of a multifaceted strategy based on automated text messaging in patients with recent heart failure admission. ESC Heart Fail. 2021 Dec;8(6):5523-5530. doi: 10.1002/ehf2.13516. Epub 2021 Sep 18.

    PubMed 34535979

Questions about this trial

What is this clinical trial studying?

A study testing Multifaceted strategy based on sending text messages(SMS) and Usual outpatient care in people with Heart Failure, run by Hospital do Coracao at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 2 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The evaluation of the effect of multifaceted intervention compared to usual outpatient care on the primary endpoint will be performed using the Student's t-Student test of the log ratio of NT-proBNP levels at 6 months baseline. (time frame: six months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04062461, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Mar 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in